 |
| ECR 2019 Abstract Submission | Invest in the Youth | Shape your Skills | ECR 2019 Timeline |
ECR 2019 Abstract Submission
Show off your
talent and gain recognition for your scientific
work at the European
Congress of Radiology (ECR), the largest
radiological meeting in Europe with over
28,000 participants! Presenting your research at
ECR is a powerful way to make international
connections and advance your career. ECR 2019
takes place February 27 to March 3 in
Vienna, Austria. Read all about the ECR 2019 abstract submission here |
|
Invest in the Youth – Support programme for trainees
ECR 2019 will offer 1,000 places to young professionals in training (radiology residents, radiography students, medical physicist residents) including free registration to ECR and an accommodation voucher. Applicants must submit an abstract for ECR 2019. |
|
Shape your Skills – Support programme for radiographers (radiological technologists)
ECR 2019 will offer support to fully trained radiographers/ radiological technologists by granting them free registration to ECR and an accommodation voucher. Applicants must submit an abstract for ECR 2019. |
|
ECR 2019 Timeline
Click here to check out
the ECR timeline and poster design for our next
congress! Stay up to date and don’t miss any
important deadlines! |
|
|
 |
|
| ESR Membership | ESR event at the European Parliament |
ESR Membership
ESR members can register for ECR 2019 for reduced fees! Make sure you become an ESR member before August 31 and enjoy all ESR benefits! Click here for more information. |
|
From health policy to practice - ESR event at the European Parliament
At the invitation of Member of the European Parliament Biljana Borzan and the ESR, MEPs, European Commission officials, patient representatives, and stakeholder organisations discussed the importance of better policy implementation to maximise benefits for patients at the European Parliament on June 6. Read our report of the event here. |
|
|
|
|
| ESOR | 25th anniversary promotion | Boost your radiation protection knowledge |
EUROPEAN SCHOOL OF RADIOLOGY (ESOR)
ESOR GALEN Advanced Course on Oncologic Imaging of the Abdomen, September 13-14, Athens (Greece) This course is aimed at senior residents, board-certified radiologists and fellows interested in abdominal oncologic imaging. Diagnostic criteria, staging principles and the clinical role of imaging in liver, pancreatic, colorectal, renal and prostate cancer will be presented. A special emphasis will be given to the applications of the latest technical advances and new European guidelines for imaging. Find more information here. ESOR ASKLEPIOS Course on Infectious and Inflammatory Disorders, September 27-28, Krakow (Poland) This course is designed for residents in their final years of training and board-certified general radiologists. A review and update of new and emerging methods for imaging of the most common infectious and inflammatory disorders will be provided. Outstanding educators will highlight the indications, explain the strengths and weaknesses of techniques available and describe the imaging features and signs for diagnosis and differential diagnosis. Check out the full programme here. |
|
ECR 2019 25th anniversary promotion
Obtain the EDiR certificate in 2018 and attend ECR 2019 for free! ECR 2019 will be the 25th to take place in Vienna, and to celebrate this very special anniversary, all European Diploma in Radiology (EDiR) candidates who succeed in an upcoming examination in 2018 and submit an abstract for ECR 2019 can attend the meeting free of charge. Click here for more information. |
|
Boost your radiation protection knowledge
EuroSafe Imaging aims, among others, at enhancing educational material and training activities in radiation protection (Action 8 of the Call for Action 2018). To do so, EuroSafe Imaging is regularly organising webinars and publishing short educational material called Tips & Tricks, which focus on radiation protection topics related to CT, interventional radiology and paediatric imaging. Test your radiation protection knowledge here and join our activities! |
|
|
|
| Safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI | Clinical applications of diffusion weighted imaging in neuroradiology | Radiomics of liver MRI predict metastases in mice | Diffusion-weighted MRI in inflammatory bowel disease | Colorectal cancer with unresectable hepatic metastases | An MRI–Based Prediction Model for Prostate Biopsy Risk Stratification |
Safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI
The goal of this study is to investigate the risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers undergoing chest x-ray, CT or follow up and verify its diagnostic value and safety. Read more here. (Eur Radiol) |
|
Clinical applications of diffusion weighted imaging in neuroradiology
This article offers a review of the main clinical uses of DWI (Diffusion-Weighted Imaging) and its recent technical improvements. Particular focus is set on physiological mechanisms which lead to diffusion abnormalities in many neurological conditions. Read the full article here. (Insights Imaging) |
|
Radiomics of liver MRI predict metastases in mice
An experimental study based on an animal model is the first to show that cancerous lesions can be detected with radiomics prior to their visibility. The implications of these findings bear potential consequences for therapy planning, in particular for surgical treatment as well as for prognosis of patients affected by colorectal cancers. Read more here. (Eur Radiol Exp) |
|
Diffusion-weighted MRI in inflammatory bowel disease
The aim of this article was to deliver a report on the use of DWI (Diffusion-Weighted Imaging) in cross-sectional MRI as an alternative to endoscopy for assessment of patients with inflammatory bowel disease (IBD). Read further here. (Lancet Gastroenterol Hepatol) |
|
Colorectal cancer with unresectable hepatic metastases
The purpose of this study was to compare and evaluate early radiological predictors in patients with unresectable CLM (colorectal cancer liver metastases) treated with bevacizumab, based on morphological response criteria and size-based criteria. Read the full article here. (Gut) |
|
An MRI–Based Prediction Model for Prostate Biopsy Risk Stratification
The authors of this article concentrate on the inclusion of MRI-based parameters in prediction models in patients with suspected prostate cancer. The study shows that MRI-based prediction models could reduce the number of unnecessary biopsies. Read more here. (JAMA Oncol) |
|
|
|
|
|
